News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Opaleye Management Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 174,508 shares
@ $1.38, valued at
$240.8k
|
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/20/2023 |
SC 13G/A
| Opaleye Management Inc. reports a 3.6% stake in Larimar Therapeutics, Inc. |
| 01/20/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/20/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 15,000 shares
@ $8, valued at
$120k
Bought 1,000 shares
@ $8, valued at
$8k
|
|
| 10/03/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 9,400 shares
@ $1.7415, valued at
$16.4k
|
|
| 09/30/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Bought 10,000 shares
@ $9.7748, valued at
$97.7k
Bought 1,085 shares
@ $9.7748, valued at
$10.6k
|
|
| 09/28/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 1,700 shares
@ $1.6924, valued at
$2.9k
|
|
| 09/26/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 6,500 shares
@ $7.9942, valued at
$52k
Bought 304 shares
@ $7.9942, valued at
$2.4k
|
|
| 09/22/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 3,411 shares
@ $1.7297, valued at
$5.9k
Bought 13,900 shares
@ $1.7297, valued at
$24k
|
|
| 09/20/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $1.8524, valued at
$18.5k
|
|
| 09/19/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 17,000 shares
@ $8.088, valued at
$137.5k
Bought 1,000 shares
@ $8.088, valued at
$8.1k
|
|
| 09/19/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $1.8733, valued at
$9.4k
|
|
| 09/16/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 3,500 shares
@ $8.1, valued at
$28.4k
Bought 658 shares
@ $8.1, valued at
$5.3k
Bought 2,000 shares
@ $8.0831, valued at
$16.2k
Bought 372 shares
@ $8.0831, valued at
$3k
|
|
| 09/15/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $8.0991, valued at
$40.5k
Bought 221 shares
@ $8.0991, valued at
$1.8k
|
|
| 09/15/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 14,100 shares
@ $3.98, valued at
$56.1k
Bought 2,500 shares
@ $3.98, valued at
$10k
Bought 5,000 shares
@ $3.8, valued at
$19k
Bought 2,300 shares
@ $3.8, valued at
$8.7k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Opaleye Management Inc. (10% Owner) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Bought 4,500 shares
@ $7.9598, valued at
$35.8k
Bought 479 shares
@ $7.9598, valued at
$3.8k
|
|
|
|
|